Journal of Affective Disorders
Volume 80, Issue 2 , Pages 155-162 , June 2004

Axis I and II comorbidity in a large sample of patients with obsessive–compulsive disorder

Received 9 September 2002 ,Revised 20 February 2003 ,Accepted 20 February 2003.

References 

  1. Bijl RV, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc. Psychiatry Psychiatr. Epidemiol. 1998;33(12):587–595
  2. Black DW, Noyes R, Pfohl B, Goldstein RB, Blum N. Personality disorder in obsessive–compulsive volunteers, well comparison subjects, and their first-degree relatives. Am. J. Psychiatry. 1993;150(8):1226–1232
  3. Brown TA, Barlow DH. Comorbidity among anxiety disorders: implications for treatment and DSM-IV. J. Consult. Clin. Psychol. 1992;60(6):835–844
  4. Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J. Abnorm. Psychol. 2001;110(4):585–599
  5. Castle DJ, Groves A. The internal and external boundaries of obsessive–compulsive disorder. Aust. N.Z. J. Psychiatry. 2000;34(2):249–255
  6. Cavedini P, Erzegovesi S, Ronchi P, Bellodi L. Predictive value of obsessive–compulsive personality disorder in antiobsessional pharmacological treatment. Eur. Neuropsychopharmacol. 1997;7(1):45–49
  7. Crino RD, Andrews G. Personality disorder in obsessive compulsive disorder: a controlled study [see comments]. J. Psychiatr. Res. 1996;30(1):29–38
  8. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–55
  9. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960;32:56–62
  10. Insel TR, Kalin NH, Guttmacher LB, Cohen RM, Murphy DL. The dexamethasone suppression test in patients with primary obsessive–compulsive disorder. Psychiatry Res. 1982;6(2):153–160
  11. Joffe RT, Swinson RP, Regan JJ. Personality features of obsessive–compulsive disorder. Am. J. Psychiatry. 1988;145(9):1127–1129
  12. Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive–compulsive disorder in five US communities. Arch. Gen. Psychiatry. 1988;45(12):1094–1099
  13. Mancini C, Van Ameringen M, Farvolden P. Does SSRI augmentation with antidepressants that influence noradrenergic function resolve depression in obsessive–compulsive disorder?. J. Affect. Disord. 2002;68(1):59–65
  14. Matsunaga H, Kiriike N, Miyata A, Iwasaki Y, Matsui T, Nagata T, et al. Personality disorders in patients with obsessive–compulsive disorder in Japan. Acta Psychiatr. Scand. 1998;98(2):128–134
  15. Ohayon MM, Shapiro CM, Kennedy SH. Differentiating DSM-IV anxiety and depressive disorders in the general population: comorbidity and treatment consequences. Can. J. Psychiatry. 2000;45(2):166–172
  16. Perugi G, Akiskal HS, Pfanner C, Presta S, Gemignani A, Milanfranchi A, et al. The clinical impact of bipolar and unipolar affective comorbidity on obsessive–compulsive disorder. J. Affect. Disord. 1997;46(1):15–23
  17. Pigott TA, L’Heureux F, Dubbert B, Bernstein S, Murphy DL. Obsessive compulsive disorder: comorbid conditions. J. Clin. Psychiatry. 1994;55(Suppl):15–27
  18. Rasmussen SA, Eisen JL. Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD. Psychopharmacol. Bull. 1988;24(3):466–470
  19. Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G. Predictors of drug treatment response in obsessive–compulsive disorder. J. Clin. Psychiatry. 1995;56(8):368–373
  20. Samuels J, Nestadt G, Bienvenu OJ, Costa PT, Riddle MA, Liang KY, et al. Personality disorders and normal personality dimensions in obsessive–compulsive disorder. Br. J. Psychiatry. 2000;177:457–462
  21. Sanderson WC, DiNardo PA, Rapee RM, Barlow DH. Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. J. Abnorm. Psychol. 1990;99(3):308–312
  22. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janans J, Weiller E, et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry. 1998;59(Supp. 20):22–33
  23. Steketee G, Eisen J, Dyck I, Warshaw M, Rasmussen S. Predictors of course in obsessive–compulsive disorder [In Process Citation]. Psychiatry Res. 1999;89(3):229–238
  24. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch. Gen. Psychiatry. 2001;58(6):590–596
  25. Tukel R, Polat A, Ozdemir O, Aksut D, Turksoy N. Comorbid conditions in obsessive–compulsive disorder. Compr. Psychiatry. 2002;43(3):204–209
  26. Welner A, Reich T, Robins E, Fishman R, Van Doren T. Obsessive–compulsive neurosis: record, follow-up, and family studies. I. Inpatient record study. Compr. Psychiatry. 1976;17(4):527–539
  27. Zimmerman M, Mattia JI. Principal and additional DSM-IV disorders for which outpatients seek treatment. Psychiatr. Serv. 2000;51(10):1299–1304

PII: S0165-0327(03)00056-9

doi: 10.1016/S0165-0327(03)00056-9

Journal of Affective Disorders
Volume 80, Issue 2 , Pages 155-162 , June 2004

Article Tools